Connect Biopharmaceuticals, Ltd. China Australia
22.06.2018 - 12:21:48Connect Biopharmaceuticals Advances CBP-201, a Novel Monoclonal Antibody Against IL-4R?, Into Clinical Development
Connect Biopharmaceuticals Advances CBP-201, a Novel Monoclonal Antibody Against IL-4R?, Into Clinical Development